Searched for
INJECTABLE OPTIONS
Three ways Trump could get a stake in AI firms for the USPresident Donald Trump is actively investigating how to ensure that the American public can benefit from the lucrative advancements within ...- Doctors find new non-surgical treatment for osteoarthritis patients that may relieve knee pain in weeksA groundbreaking minimally invasive procedure, knee embolization, is offering new hope for knee osteoarthritis sufferers. Developed by Colu...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...
- Vedanta listing: How billionaire Anil Agarwal's 'Fantastic 5' unlocked Rs 63,500 crore value with mega demergerVedanta’s long-awaited demerger culminated with the listing of four newly spun-off businesses, triggering a sharp market re-rating and unlo...
- The hidden cost of looking better: What health insurance covers, and what it leaves you to payRising demand for weight-loss drugs, cosmetic procedures and wellness treatments is creating a growing out-of-pocket healthcare expense cat...
- AstraZeneca's Enhertu gets regulatory approval in India for first-line HER2-positive breast cancerAstraZeneca Pharma India has secured approval from India's drug regulator for its smart chemotherapy drug Enhertu. This allows for its impo...
- OpenAI joins rival Anthropic in race to Wall StreetOpenAI did not disclose the size or terms of the offering, and said a timeline has not yet been determined. "It may be a while because ther...
- RBI "opens the floodgates": Dhawal Dalal on why now may be the best entry point for debt investors in two yearsIndia is attracting foreign debt capital by removing taxes and easing borrowing rules. This move is expected to inject significant liquidit...
- OpenAI files for US IPO after Anthropic as AI giants head to public marketsAI giant OpenAI has confidentially filed for a US initial public offering. This move follows rival Anthropic's similar filing. Investors ar...
- OpenAI rolls out Lockdown Mode for users handling sensitive informationOpenAI has launched Lockdown Mode to combat prompt injection attacks, a security feature designed for users handling sensitive data. This m...
- Small packs make big gains as budgets shrink and costs riseWith inflation on the rise, Indian shoppers are favoring compact product packaging. This shift not only reflects changing consumer habits b...
- Textile sector: Time for a relook as tariff tantrum may soon be history? 5 textile stocks with upside potential of up to 27%The Indian textile and apparel sector has had a stressful year. The US tariffs disrupted orders to the sector’s largest market, squeezed ma...
- Policybazaar founder warns of insurance squeeze; IT's buying spreeHappy Wednesday! Policybazaar’s Yashish Dahiya has warned that proposed commission caps could disrupt the insurance distribution industry. ...
- Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Dr Reddy’s launches oral semaglutide in IndiaDr Reddys Laboratories has launched its oral semaglutide biosimilar for type 2 diabetes in India. The drug, Obeda, is available in three ta...
- Dr Reddy's launches oral semaglutide biosimilar Obeda in IndiaDr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This i...
- The ticking price tag: What delaying parenthood really costs you financially and biologicallyA growing number of couples are choosing to delay parenthood in pursuit of career milestones, financial stability, and personal goals. But ...
- Stocks in news: Vodafone Idea, Indian Oil, Tata Steel, Dr Reddy's, PFCMarkets closed lower amid geopolitical tensions, rupee weakness, and rising inflation. Upcoming week will be sensitive to US-Iran conflict ...
Load More
